Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | |
| Operating Expenses | 21,158 | 16,045 | 9,969 | 18,795 |
| Operating Income | -21,158 | -16,045 | -9,969 | -18,795 |
| Other Income | 1,065 | 510 | 157 | 291 |
| Pre-tax Income | -20,093 | -15,535 | -9,812 | -18,504 |
| Net Income Continuous | -20,093 | -15,535 | -9,812 | -18,504 |
| Net Income | $-20,093 | $-15,535 | $-9,812 | $-18,504 |
| EPS Basic Total Ops | -0.89 | -0.84 | -1.22 | -2.75 |
| EPS Basic Continuous Ops | -0.89 | -0.84 | -1.22 | -2.75 |
| EPS Diluted Total Ops | -0.89 | -0.84 | -1.22 | -2.75 |
| EPS Diluted Continuous Ops | -0.89 | -0.84 | -1.22 | -2.75 |
| EBITDA(a) | $-21,151 | $-16,044 | $-9,771 | $-14,741 |